Adult T-Cell Leukemia (ATL) (DBCOND0044294)
Identifiers
- Synonyms
- Adult T-Cell Leukemia / Adult T-cell lymphoma/leukemia (HTLV-1-associated) / Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission / Adult T-cell leukemia/lymphoma (morphologic abnormality) / Adult T-cell leukemia/lymphoma (disorder) / Adult T-cell lymphomas/leukaemias / Adult T-cell lymphoma/leukaemia NOS / Adult T-cell lymphoma/leukaemia / Leukemia-Lymphoma, Adult T-Cell / Adult T-cell lymphoma/leukemia / Adult T-cell leukemia-lymphoma
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05377827 Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies treatment 1 active_not_recruiting NCT00117845 Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia treatment 2 terminated NCT00704691 Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas treatment 0 terminated NCT00145002 A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) treatment 3 completed NCT01378871 A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma No drug interventions treatment 2 terminated NCT01712659 Ruxolitinib for Adult T-Cell Leukemia treatment 1 / 2 terminated NCT02689453 Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) treatment 1 completed NCT00924170 Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia treatment 1 / 2 completed NCT00664677 Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia treatment 1 terminated